PD

Pannaben Dineshbhai Pandya

Active Director Director DIN 09621234
DIN 09621234 First appointment Jun 2022 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Pannaben Dineshbhai Pandya

Data last updated:

Pannaben Dineshbhai Pandya is a Director at Taumax Pharmaceuticals Private Limited (since 2022). The company operates in Pharma.

DIN 09621234
Primary Designation Director
Industry Pharma
First Appointment 01 Jun 2022
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Jun 20222021Active

Directorship timeline

Open interactive timeline →
Taumax Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Pannaben Dineshbhai Pandya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pannaben Dineshbhai Pandya

Pannaben Dineshbhai Pandya currently holds 1 directorship: Taumax Pharmaceuticals Private Limited (Director, since 01 Jun 2022).

Pannaben Dineshbhai Pandya was first appointed on 01 Jun 2022 as Director at Taumax Pharmaceuticals Private Limited.

The current boards of Pannaben Dineshbhai Pandya's companies include Ayush Dinesh Pandya (Taumax Pharmaceuticals Private Limited), Jaimini Chandrashankar Upadhyaya (Taumax Pharmaceuticals Private Limited), Shreyaskumar Vinodbhai Doshi (Taumax Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available